Venkataraman Balaji's Form 4 filing
Jasper Therapeutics, Inc. (JSPR) · filed Feb 9, 2024
- Accession no.
- 0000921895-24-000337
- Filed
- Feb 9, 2024, 8:40 PM ET
- Trade date
- Feb 8, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.53M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venkataraman BalajiCIK 0001114916 | 10% Owner |
| Avego Healthcare Capital, L.P.CIK 0001822834 | Other: See Footnote 1 |
| Velan Capital Investment Management LPCIK 0001848809 | 10% Owner |
| Avego Management LLCCIK 0001886177 | Other: See Footnote 1 |
| Morgan AdamCIK 0001964335 | 10% Owner |
| Velan Capital Holdings LLCCIK 0001964353 | Other: See Footnote 1 |
| Velan Capital Management LLCCIK 0001964355 | 10% Owner |
| Velan Capital Master Fund LPCIK 0001964356 | Other: See Footnote 1 |
| Avego Healthcare Capital Holdings, LLCCIK 0001964446 | Other: See Footnote 1 |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +350,000 | $12.95 | +$4,532,500 | 1,188,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.